Long-Term Liabilities: The sum of all non-current liabilities.
Purple Biotech Ltd. Sponsored ADR (PPBT) had Long-Term Liabilities of $0.14M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$5.76M |
|
-- |
|
-- |
|
$-6.91M |
|
$6.91M |
|
$-1.13M |
|
$5.78M |
|
$5.78M |
|
$5.78M |
|
$5.78M |
|
$5.78M |
|
$5.78M |
|
$6.91M |
|
$6.95M |
|
1.64M |
|
1.64M |
|
$4.73 |
|
$4.18 |
|
| Balance Sheet Financials | |
$8.91M |
|
$0.12M |
|
$28.13M |
|
$37.04M |
|
$3.99M |
|
-- |
|
|
Long-Term Liabilities |
$0.14M |
$4.13M |
|
$32.91M |
|
$5.07M |
|
$32.91M |
|
2.59M |
|
| Cash Flow Statement Financials | |
$-14.37M |
|
$0.51M |
|
$6.77M |
|
$14.49M |
|
$7.40M |
|
$-7.09M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.57% |
|
114.05% |
|
15.61% |
|
17.57% |
|
$12.73 |
|
$-8.76 |
|
$-8.76 |
|